Dr. Rebecca Previs

Advancing Endometrial Cancer Care with Molecular Profiling

endometrial cancer care, prognosis, precision treatment

How molecular profiling of GOG258 is changing advanced endometrial cancer care—insights on POL-E, prognosis, and precision treatment.

May 14^th • 32 mins listen

Jesus Izaguirre-Carbonell

Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing

Quest, Diagnostics, MRD, minimal residual testing, precision, biomarker

Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.

Jul 7^th • 19 mins listen

Monty Pal

Three Leaders, One Vision: Principles for Transforming Cancer Care Delivery

City of Hope, Academic Research, ASCO, precision, AI, dose strategy

Dr. Walter Stadler & Dr. Alan Bryce share how City of Hope is building a national system for smarter research, greater access, and better cancer care.

Jun 23^rd • 43 mins listen

Rebecca Previs

Tumor-Agnostic Therapies and the Future of HER2 in Oncology

diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker

What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.

Jun 8^th • 20 mins listen

Rebecca Previs

Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story

diagnostic, biomarker, lung cancer, advocacy, precision

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.

Jul 31^st • 23 mins listen

Rebecca Previs

Navigating the Future of CDXs in Oncology

precision oncology, companion diagnostics, CDx, biomarker, precision medicine

CDX expert Dawn McHugh joins Dr. Rebecca Previs to unpack the role of companion diagnostics in precision oncology and the future of cancer care.

Feb 18^th • 26 mins listen

Monty Pal

Expanding the Reach of TIL Therapy: What Will it Take?

City of Hope, Academic Research, melanoma

Dr. Mahuron shares how tumor-infiltrating lymphocyte (TIL) therapy is evolving to reach more patients and improve cancer outcomes.

Aug 4^th • 38 mins listen

Rebecca Previs

Redefining Ovarian Cancer Care with Biomarkers

diagnostic, ovarian cancer, biomarker, tumor biology

Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.

Sep 7^th • 14 mins listen

Michael Pietrack

Season 2, Episode 21: A Century of X-Rays with Margaret Yu

In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care. Dr. Yu unpacks the 130-year history of radiation in medi…

Oct 27^th • 20 mins listen